Rishi P. Singh, MD, talked about gene therapy studies for neovascular age-related macular degeneration presented at the ASRS meeting in a video interview with Healio.
Singh, staff surgeon at Cole Eye Institute, Cleveland Clinic, and associate professor of ophthalmology at Lerner College of Medicine, discussed emerging research in suprachoroidal delivery for gene therapy and intravitreal gene therapy.
“I think for gene therapy to be sufficient enough to replace therapy, it has to have the ability to have low side effect profiles, which it currently does not in the intravitreal form,”